Literature DB >> 962400

Long-term survival after resection for bronchogenic carcinoma.

D L Paulson, J S Reisch.   

Abstract

Of 915 resections for bronchogenic carcinoma over a 25-year period (1945-1969), 249 patients survived over 5 years; 127 of the patients eligible survived over 10 years, 61 over 15 years, and 22 over 20 years. The case material was divided into three time periods: 1945-49, 1950-59 and 1960-69, as well as by extent of resection. Lobectomy became the operation of choice, pneumonectomy being reserved for the more extensive lesions. Observed survival rates at 5, 10 and 15 years for 561 patients in the lobetomy series were 35, 22 and 15%, respectively, but strikingly increased to 41, 28 and 19% in the 1960-69 period. Observed rates for 354 patients having pneumonectomies were similar for three time periods, being 16, 8 and 6% at 5, 10 and 15 years, respectively. Relative survival rates for the lobectomy series at 5, 10 and 15 years rose from 33, 28 and 26%, repectively, in the 1950-59 period to 50, 39 and 35% in the last time period, becoming a near horizontal curve segment after 5 years. Dominant factors in survival were extent of the lesion and stage of nodal involvement, histologic type and location being less significant.

Entities:  

Mesh:

Year:  1976        PMID: 962400      PMCID: PMC1344391          DOI: 10.1097/00000658-197609000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  The relative survival rate: a statistical methodology.

Authors:  F EDERER; L M AXTELL; S J CUTLER
Journal:  Natl Cancer Inst Monogr       Date:  1961-09

2.  Relationship of cell type and lymph node metastasis to survival after resection of bronchial carcinoma.

Authors:  T W Shields; J Yee; J H Conn; C D Robinette
Journal:  Ann Thorac Surg       Date:  1975-11       Impact factor: 4.330

3.  Appraisal of choice and results of treatment for bronchogenic carcinoma.

Authors:  E Carlens
Journal:  Chest       Date:  1974-04       Impact factor: 9.410

4.  Selectivity in the surgical treatment of bronchogenic carcinoma.

Authors:  D L Paulson; H C Urschel
Journal:  J Thorac Cardiovasc Surg       Date:  1971-10       Impact factor: 5.209

5.  Operative mortality and 5-year survival rates in men with bronchogenic carcinoma.

Authors:  W Weiss; D A Cooper; K R Boucot
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

  5 in total
  7 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 2.  Chemotherapy in lung cancer.

Authors:  C G Price; M L Slevin
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

Review 3.  The management of lung cancer.

Authors:  S G Spiro
Journal:  Lung       Date:  1982       Impact factor: 2.584

4.  Pneumonectomy for non-small cell lung cancer.

Authors:  Yoshinobu Ichiki; Akira Nagashima; Yasuhiro Chikaishi; Manabu Yasuda
Journal:  Surg Today       Date:  2012-04-07       Impact factor: 2.549

5.  Carcinoid tumours of the bronchus: a 33 year experience.

Authors:  R Hurt; M Bates
Journal:  Thorax       Date:  1984-08       Impact factor: 9.139

6.  Resectional surgery in the treatment of primary carcinoma of the lung with mediastinal lymph node metastases.

Authors:  I Rubinstein; G L Baum; Y Kalter; Y Pauzner; Y Lieberman; J J Bubis
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

Review 7.  Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.

Authors:  Ya-Ping Xu; Bo Li; Xiao-Ling Xu; Wei-Min Mao
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.